FDA Approves First Cancer Vaccine
FDA approved the first time and allows the use of a cancer vaccine is a vaccine for prostate cancer. Previously existing research on prostate cancer vaccine, the vaccine is still only in the research.
Called Provenge, a vaccine targeting prostate cancer. This vaccine is not for healing, also not as given preventive vaccine for measles, hepatitis or cervical cancer. But this is a therapeutic vaccine, which means enhancing the immune system of patients. This vaccine is used after prostate cancer has been diagnosed with certainty.
Dozens of other vaccines are being developed for various types of cancer, but Provenge is the first to obtain FDA approval stamp.
Current cancer treatments, such as radiation, chemotherapy and even removal of the prostate, can cause damage to other body functions. This vaccine is beneficial for the body's natural defense system is an important alternative therapy. It also has fewer side effects - most of the patients who use Provenge reported fever, fatigue and pain.
Provenge is intended for men with prostate cancer that has spread throughout the body. In 2009, we are about 192,000 new prostate cancer cases are diagnosed and about 27,000 people die from the disease, according to the National Cancer Institute.
Official Website Provenge - www.provenge.com
This is the First Cancer Vaccine FDA-approved Is original article written, if you find that This is the First Cancer Vaccine FDA-approved is violating DMCA please don't hesistate to contact me http://the-healtharticles.blogspot.com/2013/10/first-cancer-vaccine-fda-approved.html, and Thank For Visit Health Articles Blog.